DEEPNOID Inc. (KOSDAQ:315640)

Market Cap	141.16B
Revenue (ttm)	11.45B
Net Income (ttm)	-10.04B
Shares Out	22.44M
EPS (ttm)	-414.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,713
Average Volume	144,263
Open	6,470.00
Previous Close	6,480.00
Day's Range	6,230.00 - 6,470.00
52-Week Range	4,160.00 - 9,090.00
Beta	0.87
RSI	44.44
Earnings Date	Aug 14, 2025

About DEEPNOID

DEEPNOID Inc. provides medical artificial intelligence solutions. The company offers its solutions under the DEEP:NEURO, DEEP:LUNG, DEEP:SPINE, DEEP:CHEST, DEEP:BREAST, DEEP:ENDO, DEEP:DENTAL, DEEP:FUNDUS, DEEP:PATH, and DEEP LIVER names. Its solutions analyzes clinical data related to diseases, such as medical images, including CT, MRI, X-ray, and pathological images dealing with disease-related cells and tissues, and electronic medical records (EMR) of hospitals. The company was founded in 2008 and is based in Seoul, South Korea.

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2008
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 315640

Financial Performance

In 2024, DEEPNOID's revenue was 10.85 billion, an increase of 461.15% compared to the previous year's 1.93 billion. Losses were -9.08 billion, 34.7% more than in 2023.